Literature DB >> 6694677

Cyclosporine in refractory severe aplastic anemia.

P A Stryckmans, J P Dumont, T Velu, L Debusscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6694677     DOI： 10.1056/NEJM198403083101013

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Cyclosporin A in aplastic anemia--report of a workshop.

Authors:  H Schrezenmeier; M Schlander; A Raghavachar
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

2.  Gold-induced aplastic pancytopenia: 14-month survival through multiple transfusions.

Authors:  R Reychler; T De Geeter; L A Verbruggen
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

3.  Immunosuppressive treatment of aplastic anemia: a prospective, randomized multicenter trial evaluating antilymphocyte globulin (ALG) versus ALG and cyclosporin A.

Authors:  N Frickhofen; J P Kaltwasser
Journal:  Blut       Date:  1988-04

4.  Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor.

Authors:  W Schwinger; C Urban; H Lackner; C Mache
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

Review 5.  Pathophysiology and treatment of aplastic anemia.

Authors:  Klaus Geissler
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

6.  Posttransfusional, LKM-1-autoantibody-positive hepatitis C virus infection, cryoglobulinemia, and aplastic anemia.

Authors:  M Peters; M Trippler; H Löhr; W Gödderz; W Herr; S Störkel; K H Meyer zum Büschenfelde; G Gerken
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

7.  Cyclosporine A treatment in four cases of aplastic anemia.

Authors:  A Porwit; P Panayotides; E Mansson; E Osby; R Hast; P Reizenstein
Journal:  Blut       Date:  1987-02

Review 8.  Recent advances in treatment of aplastic anemia.

Authors:  Seung Hwan Shin; Sung Eun Lee; Jong Wook Lee
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

9.  Cyclosporine monotherapy for severe aplastic anemia: a developing country experience.

Authors:  Jameel Al-Ghazaly; Waled Al-Dubai; A K Al-Jahafi; Munasser Abdullah; Adela Al-Hashdi
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526

10.  Immunomodulation therapy for severe aplastic anemia--ALG versus ALG plus cyclosporin A.

Authors:  C W Park; C H Han; C C Kim; D J Kim; H K Kim
Journal:  Korean J Intern Med       Date:  1989-01       Impact factor: 2.884
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.